Cargando…

Clinical Value of Multiomics-Based Biomarker Signatures in Inflammatory Bowel Diseases: Challenges and Opportunities

Inflammatory bowel diseases (IBDs), encompassing Crohn's disease and ulcerative colitis, are complex and heterogeneous diseases characterized by a multifactorial etiology, therefore demanding a multimodal approach to disentangle the main pathophysiological components driving disease onset and p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourgonje, Arno R., van Goor, Harry, Faber, Klaas Nico, Dijkstra, Gerard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371325/ https://www.ncbi.nlm.nih.gov/pubmed/36881831 http://dx.doi.org/10.14309/ctg.0000000000000579

Ejemplares similares

Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Crohn’s Disease in Clinical Remission Is Marked by Systemic Oxidative Stress
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Patients With Inflammatory Bowel Disease Show IgG Immune Responses Towards Specific Intestinal Bacterial Genera
por: Bourgonje, Arno R., et al.
Publicado: (2022)

HIF1α-Dependent Induction of TFRC by a Combination of Intestinal Inflammation and Systemic Iron Deficiency in Inflammatory Bowel Disease
por: Fagundes, Raphael R., et al.
Publicado: (2022)

Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease
por: Gabriëls, Ruben Y., et al.
Publicado: (2022)

Proteomic analyses do not reveal subclinical inflammation in fatigued patients with clinically quiescent inflammatory bowel disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Increased fecal calprotectin levels in Crohn’s disease correlate with elevated serum Th1- and Th17-associated cytokines
por: Bourgonje, Arno R., et al.
Publicado: (2018)

A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Assessing intestinal permeability in Crohn’s disease patients using orally administered (52)Cr-EDTA
por: von Martels, Julius Z. H., et al.
Publicado: (2019)

Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets
por: Bourgonje, Arno R., et al.
Publicado: (2023)

The effect of iron therapy on oxidative stress and intestinal microbiota in inflammatory bowel diseases: A review on the conundrum
por: Loveikyte, R., et al.
Publicado: (2023)

Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab
por: Loveikyte, Roberta, et al.
Publicado: (2023)

Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn’s Disease
por: Alexdottir, Marta S., et al.
Publicado: (2022)

Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn’s Disease
por: Alexdottir, Marta S., et al.
Publicado: (2022)

The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease
por: Bourgonje, Arno R, et al.
Publicado: (2021)

Inflammatory Bowel Disease in Asia: The Challenges and Opportunities
por: Hu, Pin-Jin
Publicado: (2015)

Tendon and multiomics: advantages, advances, and opportunities
por: Sarmiento, Paula, et al.
Publicado: (2021)

Analyzing the intestinal microbiome in inflammatory bowel disease: From RNA to multiomics
por: Lett, Bron, et al.
Publicado: (2020)

Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
por: Parada Venegas, Daniela, et al.
Publicado: (2019)

Corrigendum: Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
por: Parada Venegas, Daniela, et al.
Publicado: (2019)

Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohnʼs disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Serum free thiols predict cardiovascular events and all-cause mortality in the general population: a prospective cohort study
por: Abdulle, Amaal E., et al.
Publicado: (2020)

Opportunities and challenges for synthetic biology in the therapy of inflammatory bowel disease
por: Dong, Yumeng, et al.
Publicado: (2022)

Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Detecting the Multiomics Signatures of Factor-Specific Inflammatory Effects on Airway Smooth Muscles
por: Zhang, Yu-Hang, et al.
Publicado: (2021)

Multiomic Approaches for Cancer Biomarker Discovery in Liquid Biopsies: Advances and Challenges
por: Diaz, Paola Monterroso, et al.
Publicado: (2023)

Harnessing the potential of spatial multiomics: a timely opportunity
por: Li, Xuexin
Publicado: (2023)

Local and Systemic Oxidative Stress Biomarkers for Male Infertility: The ORION Study
por: Bergsma, Anna T., et al.
Publicado: (2022)

A Sex-Specific Comparative Analysis of Oxidative Stress Biomarkers Predicting the Risk of Cardiovascular Events and All-Cause Mortality in the General Population: A Prospective Cohort Study
por: Bourgonje, Martin F., et al.
Publicado: (2023)

New opportunities and challenges of natural products research: When target identification meets single-cell multiomics
por: Zhu, Yuyu, et al.
Publicado: (2022)

A multiomic ferroptosis-associated prognostic signature incorporating epigenetic and transcriptional biomarkers for hepatocellular carcinoma
por: Chen, Jida, et al.
Publicado: (2022)

Multiomics signatures of type 1 diabetes with and without albuminuria
por: Clos-Garcia, Marc, et al.
Publicado: (2022)

Multiomic sequencing of paired primary and metastatic small bowel carcinoids
por: Postel, Mackenzie D., et al.
Publicado: (2023)

Multiomics-empowered Deep Phenotyping of Ulcerative Colitis Identifies Biomarker Signatures Reporting Functional Remission States
por: Janker, Lukas, et al.
Publicado: (2023)

Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification
por: Lopez-Siles, Mireia, et al.
Publicado: (2020)

Inulin-grown Faecalibacterium prausnitzii cross-feeds fructose to the human intestinal epithelium
por: Fagundes, Raphael R., et al.
Publicado: (2021)

Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease
por: Otten, Antonius T., et al.
Publicado: (2022)

Both LDL and HDL particle concentrations associate positively with an increased risk of developing microvascular complications in patients with type 2 diabetes: lost protection by HDL (Zodiac-63)
por: Bourgonje, Arno R., et al.
Publicado: (2023)

Plasma Citrate Levels Are Associated with an Increased Risk of Cardiovascular Mortality in Patients with Type 2 Diabetes (Zodiac-64)
por: Bourgonje, Arno R., et al.
Publicado: (2023)

Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities
por: Lippi, Giuseppe, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s13ktop6d5v80j4t6o0k5ljgl0